31 Mar 2022
Assets52.91
Total Income30.17
Profit After Tax0.25
NET Worth7.49
Reserves and Surplus3.49
Total Borrowing29.52
At a glance
Updated 2026-08-24The shares listed at ₹137.45, a 1.81% move from the issue price. Astonea Labs is a SME IPO with an issue size of ₹37.67 crore, proposed for listing on BSE SME. The offer opens on 27th May 2025 and closes on 29th May 2025. The issue structure includes a fresh issue of ₹35.72 crore. The current listing schedule points to 3rd Jun 2025.
Issue details
Listing atBSE SME
Issue typeBook Build Issue
Issue size₹37.67 Cr
Fresh issue₹35.72 Cr
Face value₹10
Price band₹128.00–₹135.00
Allotment30th May 2025
Listing3rd Jun 2025
Listing performance
Full performance ↗Issue price₹135.00
Listing price₹137.45
Current price—
Listing gain1.81%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹0.00
GMP / upper price0.00%
Est. listing₹135.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens27th May 2025
Closes29th May 2025
Allotment30th May 2025
Refund2nd Jun 2025
Demat2nd Jun 2025
Listing3rd Jun 2025
Subscription demand
Full bidding ↗Total1.79×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1000 | ₹135,000 |
Company
Incorporated2017
Use of proceeds
| Object | Amount |
|---|---|
| Funding of expenses proposed to be incurred towards registration in Bolivia, South America | ₹1.29 Cr |
| Purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the 2nd floor of the Existing Premises | ₹5.23 Cr |
| Advertising, marketing and brand building | ₹4.95 Cr |
| Investment in procuring hardware and software | ₹0.68 Cr |
| Funding of Working Capital Requirements | ₹19.75 Cr |
| General Corporate Purposes | ₹1.99 Cr |
| Issue Expenses | ₹3.77 Cr |
| Total | ₹37.67 Cr |
Financials
Full financials ↗31 Mar 2023
Assets64.28
Total Income67.26
Profit After Tax0.67
NET Worth8.16
Reserves and Surplus4.16
Total Borrowing35.99
31 Mar 2024
Assets80.89
Total Income80.29
Profit After Tax3.81
NET Worth11.97
Reserves and Surplus4.37
Total Borrowing42.40
31 Dec 2024
Assets96.52
Total Income69.69
Profit After Tax4.10
NET Worth17.28
Reserves and Surplus9.56
Total Borrowing49.48
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 37.86% |
| ROCE | 22.95% |
| Debt / Equity | 2.16% |
| RoNW | 31.83% |
| PAT Margin | 4.75% |
| EBITDA Margin | 14.60% |
| Price to Book Value | 8.57 |
Valuation & shareholding
Pre-IPO EPS4.93
Post-IPO EPS5.20
Pre-IPO P/E27.36
Post-IPO P/E25.94
Promoter holding pre98.42%
Promoter holding post72.3%
Market cap₹141.90 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Funding of expenses proposed to be incurred towards registration in Bolivia, South America | ₹1.29 Cr |
| Purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the 2nd floor of the Existing Premises | ₹5.23 Cr |
| Advertising, marketing and brand building | ₹4.95 Cr |
| Investment in procuring hardware and software | ₹0.68 Cr |
| Funding of Working Capital Requirements | ₹19.75 Cr |
| General Corporate Purposes | ₹1.99 Cr |
| Issue Expenses | ₹3.77 Cr |
| Total | ₹37.67 Cr |
Registrar & lead managers
Registrar
Kfin Technologies Ltd.Lead managers
- Oneview Corporate Advisors Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.